Abstract:Allogeneic haemopoietic stem-cell transplantation (HSCT) is a definitive cure for many malignant blood diseases. Ideal donors for transplantation are those with completely matched human leukocyte antigen (HLA), kin-relative or no-kin-relative. However only about 25% to 30% people could find HLA matched related-donor and there is only 1/100,000 opportunity to find a matched HLA in unrelated group. Recent years HLA haploidentical transplantation play more and more important role in across the histocompatibility barrier and make about 90% patients possible to get transplantation. However GVHD is still main problem during the transplantation. Recent studies show that natural killer (NK) cells could specially attack recipient antigen-presenting cells (APCs), shown to be responsible for decreasing and improving GVHD. To explore the effect of NK cell on GVHD after H-2 haploidentical bone marrow transplantation(BMT) in mice, we purified NK cells by positive selection with CD49b (DX5) MicroBeads (Miltenyi Biotec product) from donor mice as ingredient in the conditioning regimens, and observed the influence of donor NK cells on GVHD and evaluated the potential role of donor NK cells in protecting against GVHD. Murine model of H-2 haploidentical BMT was established by using Balb/c(H-2d) mouse as recipient, and Balb/c (H-2d)×C57BL/6 (H-2b)(H-2d/b) mouse as donor. Lethally irradiated Balb/c(H-2d) mice were transplanted with Balb/c(H-2d)×C57BL/6(H-2b)(H-2d/b) bone marrow containing donor peripheral T cells and/or NK cells. GVHD and survival rate were studied by observing clinical manifestations and pathological changes. In the group with bone marrow plus T cells, GVHD was induced in 90% mice; but in the group plus with low concentration of NK cells, GVHD was induced in 20% mice; and in the group transplanted with high concentration of NK cells, GVHD was induced only in 10% mice. Compared with the group transplanted only with T cells, the incidences of GVHD in the latter two groups decreased obviously (P<0.01) and the survival rate at 15, 30, 45 and 60 days increased obviously (P<0.01). In mouse H-2 haploidentical BMT, alloreactive NK cells can reduce the incidence of GVHD and increase the survival rate after transplantation in mice.

Transduction of MHC Gene Induces Transplantation Tolerance ( I )- Transduction of H-2k~b Gene into Mice Hematopoietic Cells

Inhibition of Alloimmune Response Induced by a Plasmid Vector-Transducted IL-10 Gene Therapy after Heart Transplantation in Mice

Transfer of Multiple Loci of Donor's Genes to Induce Recipient Tolerance in Organ Transplantation.

Mouse Heterotopic Abdominal Heart Transplant Model

Tolerance Induced by IL-6 Deficient Donor Heart is Significantly Involved in Myeloid-Derived Suppressor Cells (Mdscs).

Cardiac Allograft Tolerance Induced by Isogeneic CD4+CD25+ Regulatory T Cells.

Rerovirus Mediated Hsv-Tk Gene Transfer Can Influence The Function Of Human T-Lymphocyte

Assessment Of Re-188 Marked Anti Mhc Class Ii Antibody By Peripheral Blood Mononuclear Cells Stimulated By Donor Alloantigen

[Influence of Mouse Genetic Engineering Regulatory T Cells Infusion on Post-Allogeneic Bone Marrow Transplantation Acute Graft-Versus-host Disease in Mice].

Tolerance induction between two different strains of parental mice prevents graft-versus-host disease in haploidentical hematopoietic stem cell transplantation to F1 mice.

Evidence for a gene controlling the induction of transplantation tolerance

DIRECT AND INDIRECT RECOGNITION IN PIG-TO-MAN XENOTRANSPLANTATION

Study on the Induction of Transplantation Tolerance in Mice by Continuous Infusion of Donor Spleen Cells and Its Mechanisms

Mir-152 May Silence Translation Of Camk Ii And Induce Spontaneous Immune Tolerance In Mouse Liver Transplantation

[Experimental Study of Tripterygium Hypoglaucum (level) Hutch on Preventing Acute Graft-Versus-host Disease in Bone Marrow Transplantation Mice].

Vulnerability of allografts to rejection by MHC class II-restricted T-cell receptor transgenic mice.

Immune Tolerance of Allogeneic T Cells Induced by Dendritic Cells Genetically Engineered to Express Iκ Bα Mutant

Effect of NK Cells on GVHD in H-2 Haploidentical Bone Marrow Transplantation in Mice

Induction of tolerance and prolongation of islet allograft survival by syngeneic hematopoietic stem cell transplantation in mice

Animal Model of Adoptive Transfer after Oral Tolerance

Improvement of Transplantation Tolerance of Skin Allograft by Infusion of Donor Bone Marrow Cells and Its Mechanism